BELLAME BOWER: Open Payments
NPI 1134873540 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $395 · 2025 $315
Food & beverage: $288Education: $28
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| GENZYME CORPORATION | 2 | $51 |
| Resmed Corp | 1 | $28 |
| PFIZER INC. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| JAZZ PHARMACEUTICALS INC. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $17 |
Products named: ZEPBOUND, NUCALA, DUPIXENT, AIRSENSE, CUTAQUIG, GLASSIA, XYWAV, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
